HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cerebral antivasoconstrictive effects of flunarizine.

Abstract
Flunarizine is a selective Ca++-antagonist with weaker H1-histaminergic antagonistic properties. Flunarizine reduces vasospasm caused by an exaggerated Ca++-influx in depolarized arteries and by vasoactive substances released from aggregating platelets. This Ca++-antagonist also antagonizes the mutual amplification of the vasoconstrictor action of the platelet products. Flunarizine is particularly effective in the cerebral blood vessels, also when they are hyperreactive because of hypoxia. The compound does not interfere with normal arteriolar autoregulation or heart function. Thus flunarizine may be particularly effective in preventing vasospasm without lowering blood pressure or inducing a steal phenomenon.
AuthorsJ M Van Nueten, W J Janssens
JournalActa oto-laryngologica. Supplementum (Acta Otolaryngol Suppl) Vol. 460 Pg. 42-9 ( 1988) ISSN: 0365-5237 [Print] Norway
PMID3074619 (Publication Type: Journal Article, Review)
Chemical References
  • Flunarizine
Topics
  • Animals
  • Cerebral Veins (drug effects, physiology)
  • Flunarizine (pharmacology)
  • Humans
  • Vasoconstriction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: